Is Viking Therapeutics Ready For Another Surge?

Viking Therapeutics NASDAQ: VKTX has captured the attention of investors, with its stock price skyrocketing over 400% in one year. This remarkable performance stems from the company's promising clinical trial results for VK2735, an investigational weight loss drug that has demonstrated promising efficacy in oral and injectable forms. Viking Therapeutics Today VKTX Viking Therapeutics $62.32 -0.81 (-1.28%) 52-Week Range $8.28 ▼ $99.41 Price Target $108.60 Add to Watchlist The company is expected to report it ...